Clinical Cancer Bulletin is a peer-reviewed english-language open-access journal published by Springer Nature in Singapore, operating under an open-access model since 2023. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors publish in Clinical Cancer Bulletin without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY license (see other journals using this license).
Keywords
oncology, cancer treatment, clinical oncology
At a glance
- Publisher
- Springer Nature
- Country
- Singapore
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2023
ISSN
- electronic
- 2791-3937
Frequently asked questions
Is Clinical Cancer Bulletin peer-reviewed?
Yes — Clinical Cancer Bulletin operates a Anonymous peer review review process.
Does Clinical Cancer Bulletin charge an article processing charge (APC)?
No. Clinical Cancer Bulletin does not charge any APC. Publication is free for accepted authors.
What subjects does Clinical Cancer Bulletin publish?
Clinical Cancer Bulletin publishes research in Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
What languages does Clinical Cancer Bulletin accept?
Clinical Cancer Bulletin accepts manuscripts in English.
What is the ISSN of Clinical Cancer Bulletin?
ISSN:
2791-3937 (electronic).How do I submit a manuscript to Clinical Cancer Bulletin?
Submit through the journal's official portal: visit submission page →